Searched for: subject%3A%22Drug%255C%2BEvaluation%252C%255C%2BPreclinical%22
(1 - 13 of 13)
document
Santos, A.F. (author), Zaltsman, A.B. (author), Martin, R.C. (author), Kuzmin, A. (author), Alexandrov, Y. (author), Roquemore, E.P. (author), Jessop, R.A. (author), Erck, M.G.M.V. (author), Verheijen, J.H. (author), TNO Kwaliteit van Leven (author)
Angiogenesis is a general term describing formation of new tube-like microvessel sprouts that are the size of capillary blood vessels. Angiogenesis is fundamental in key stages of embryonic development, organ formation, and wound repair and is also involved in the development and progression of a variety of pathological conditions, including...
article 2008
document
Pires, N.M.M. (author), Jukema, J.W. (author), Daemen, M.J.A.P. (author), Quax, P.H.A. (author), TNO Kwaliteit van Leven (author)
In 2001, the first human study with drug-eluting stents (DES) was published showing a nearly complete abolition of restenosis by using a sirolimus-eluting stent. This success was very encouraging to test new compounds in combination with the DES platform. Nevertheless, several other anti-restenotic compounds have been used in human clinical...
article 2006
document
Parnham, M.J. (author), Bogaards, J.J.P. (author), Schrander, F. (author), Schut, M.W. (author), Orešković, K. (author), Mildner, B. (author), TNO Kwaliteit van Leven (author)
PLD-118 is a novel, oral antifungal drug, under development for the treatment of Candida infections. Possible metabolism of PLD-118 by rat, dog and human S9 liver homogenates and inhibition of human cytochrome P450 (CYP) enzymes were investigated. PLD-118 (10 and 100 μm) incubated for 0-60 min with S9 fractions and NADPH was determined by HPLC,...
article 2005
document
van der Greef, J. (author), McBurney, R.N. (author), TNO Kwaliteit van Leven (author)
The pharmaceutical industry is currently beleaguered by close scrutiny from the financial community, regulators and the general public. Productivity, in terms of new drug approvals, has generally been falling for almost a decade and the safety of a number of highly successful drugs has recently been brought into question. Here, we discuss...
article 2005
document
de Ligt, R.A.F. (author), van der Klein, P.A.M. (author), von Frijtag Drabbe Künzel, J.K. (author), Lorenzen, A. (author), El Maate, F.A. (author), Fujikawa, S. (author), van Westhoven, R. (author), van den Hoven, T. (author), Brussee, J. (author), Ijzerman, A.P. (author), TNO Voeding (author)
Novel 3,8- and 8,9-disubstituted N6-cyclopentyladenine derivatives were synthesised in moderate overall yield from 6-chloropurine. The derivatives were made in an attempt to find a new neutral antagonist with high affinity for adenosine A1 receptors. N6-Cyclopentyl-9- methyladenine (N-0840) was used as a lead compound. Binding affinities of the...
article 2004
document
Brok, H.P.M. (author), Tekoppele, J.M. (author), Hakimi, J. (author), Kerwin, J.A. (author), Nijenhuist, E.M. (author), de Groot, C.W. (author), Bontrop, R.E. (author), Hart 't, B.A. (author), Gaubius Instituut (author)
CIA in the rhesus monkey is an autoimmune-based polyarthritis with inflammation and erosion of synovial joints that shares various features with human rheumatoid arthritis (RA). The close phylogenetic relationship between man and rhesus monkey makes the model very suitable for preclinical safety and efficacy testing of new therapeutics with...
article 2001
document
Gaubius Instituut TNO (author), van Vlijmen, B.J.M. (author), Pearce, N.J. (author), Bergö, M. (author), Staels, B. (author), Yates, J.W. (author), Gribble, A.D. (author), Bond, B.C. (author), Hofker, M.H. (author), Havekes, L.M. (author), Groot, P.H.E. (author)
Apolipoprotein (APO) E*3-Leiden mice with impaired chylomicron and VLDL (very low density lipoprotein) remnant metabolism display hyperlipidaemia and atherosclerosis. In the present study, these mice were used for testing the hypolipidaemic effect of two marketed agents, lovastatin (CAS 75330-75-5) and gemfibrozil (CAS 25812-30-0) as well as a...
article 1998
document
van der Kaaden, M.E. (author), Rijken, D.C. (author), Kruijt, J.K. (author), van Berkel, T.J.C. (author), Kuiper, J. (author), TNO Preventie en Gezondheid (author)
Urokinase-type plasminogen activator (u-PA) is used as a thrombolytic agent in the treatment of acute myocardial infarction. In vitro, recombinant single-chain u-PA (rscu-PA) expressed in E. coli is recognized by the Low-Density Lipoprotein Receptor-related Protein (LRP) on rat parenchymal liver cells. In this study we investigated the role of...
article 1997
document
Prinsen, M.K. (author), Instituut CIVO-Toxicologie en Voeding TNO (author)
The enucleated eye test with chicken eyes (CEET) obtained from an abattoir proved to be a valuable and practical alternative for the 'traditional' enucleated eye test with eyes of laboratory rabbits. Since 1992, the CEET has been incorporated in standard contract toxicity testing at the Toxicology Division of the TNO Nutrition and Food Research...
article 1996
document
Kulig, B. (author), Alleva, E. (author), Bignami, G. (author), Cohn, J. (author), Cory-Slechta, D. (author), Landa, V. (author), O'donoghue, J. (author), Peakall, D. (author), Centraal Instituut voor Voedingsonderzoek TNO (author)
Chemicals/CAS: Neurotoxins
article 1996
document
Koëter, H.B.W.M. (author), Centraal Instituut voor Voedingsonderzoek TNO (author)
Toxicity data of 37 compounds tested in both a subchronic study and one or more studies focused on reproduction were evaluated to obtain information on the significance of fertility and reproduction parameters in setting no-effect levels (NEL). It appeared that a) the test system aimed at reproduction and development was more sensitive than the...
article 1983
document
Kroes, R. (author), Instituut CIVO-Toxicologie en voeding TNO (author)
Short-term tests designed to detect possible carcinogenicity have been extensively refined during the last years. Presently, many more or less simple and convenient systems are available to detect mutations, chromosome effects, DNA damage, and malignant transformation. Although their relevance to carcinogenicity is often reasonably good,...
article 1983
document
Kilbey, B.J. (author), Igali, S. (author), Lohman, P.H.M. (author), Medisch Biologisch Laboratorium TNO (author)
A statement of general principles and minimal criteria for the screening of chemicals for potential mutagenicity in man that may be used as guidelines for regulatory agencies and industrial organisations. To make clear the potentialities and current limitations of short-term mutagenicity testing for the prediction of genetic and carcinogenic...
article 1978
Searched for: subject%3A%22Drug%255C%2BEvaluation%252C%255C%2BPreclinical%22
(1 - 13 of 13)